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ABSTRACT
Studies have shown that the sharing of big health data can
improve patient management across primary and secondary
care sectors. It can also reduce costs and can enhance the
medical research process. Unfortunately, many big health data
initiatives are being impeded because of a range of complex
issues. This study was initiated to identify the said issues
and develop a tool for health marketers to use to negate the
barriers in big healthcare data projects. The study
demonstrates how the Interactive Communication Technology
Adoption Model can be operationalized to support qualitative
researchers.
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Back in 2013, England’s National Health Service (NHS) introduced a pro-
gramme called Care.data. It was designed to integrate the primary and sec-
ondary care sectors, giving commissioners a more holistic view of its
existing and potential services across community, GP [General
Practitioners], and hospital settings (NHS, 2013). This type of programme
can also enhance the medical research process (Foley & Lie, 2019;
Hemingway et al., 2018; Limb, 2016, Swenson et al., 2018), and can be
positioned as the management of “big data” or “big healthcare data” (see
van Staa et al., 2016). Big healthcare data reached great prominence during
the 2020/21 COVID-19 pandemic, particularly with the launch of the vari-
ous track and trace systems. Yet these initiatives were impeded in many
countries because of concerns surrounding the protection of personal data
(Fahey & Hino, 2020). A similar issue was experienced by the Care.data
programme, which resulted in it being abandoned in 2016 (Godlee, 2016).
Research into why the public is adverse in accepting such technology and
the internet must arguably remain a priority, particularly as it has been
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demonstrated to provide clear societal benefits (see Foley & Lie, 2019;
Hemingway et al., 2018; Limb, 2016; Sheng & Simpson, 2015). This “gap”
and “lack of understanding” was the catalyst for embarking on this
research, we have chosen to critically investigate the issues which contrib-
ute to theory and knowledge by addressing the concerns raised by Lupton
(2016): i.e., there is not enough critical investigation in this area. It will
focus on society’s perceived attitudes and acceptance of big healthcare from
a health marketeer’s perspective. More specifically, it will be restricted to
those marketeers linked to NHS England. The study uses Lin’s (2003)
Interactive Communication Technology Adoption Model as its theoretical
framework. The study’s primary aim was to develop a tool for health mar-
keteers to use to help identify perceived barriers in big healthcare data
projects with possible solutions in how they can be resolved.
Big health data
The sharing of big health data is contentious, with some researchers stating
it should be a “moral duty” (Kalkman et al., 2019a, 2019b) while others
believe that the public should control their own data (Godlee, 2016). That
said, there can be no denying that big health data can be used to make bet-
ter care decisions, predict future events, understand the spread of disease
and help to commission services for the healthcare providers (Foley & Lie,
2019). Fox (2017) brings a different perspective; he has implored us to be
wary of technological advances in the health sector because of its possible
associations to neoliberal marketing. This neoliberal marketing has links to
corporate organizations and the monetizing of patient data which fuels the
public’s mistrust. Such a warning is supported by Ebeling (2016), who
warns that digitizing the health sector will not happen until the data own-
ership is resolved. These findings are all associated with Fahey and Hino
(2020) work, which states that the inability to gain agreement on how best
to manage privacy concerns has fueled public mistrust. This means that
health services and Governmental bodies must make it clear that the need
for health data privacy is sacrosanct.
Current literature also states that the general public is unaware of how
the health data might be used, and who has access to it (Ritchie et al.,
2015; van Staa et al., 2016). Although, Hill et al. (2013) research discovered
the public become more compliant and acquiescent when they were edu-
cated on its use. This is why we have chosen to focus on understanding the
perceptions of health marketeers: their future campaigns could help educate
society. That said, the issue of data privacy and how the data might be
used is not the only concern, Krumholz (2014) believes that security factors
have also caused the public and non-governmental organizations (NGOs)
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to be skeptical of big health data. Brown et al. (2010) believe that these
concerns can be overcome by better processes and procedures. This is sup-
ported by Botrugno (2019) who states that the implementation of ITs
(which we have assumed to also included the handling of big data) must
be meticulous to keep medical standards high.
In summary, current literature states that gaining public acceptance to
use their health data more widely is only likely to happen if it can be
shown that their privacy will always be protected, and security issues will
be kept at a minimum. But what mediums, mechanisms, and/or models
should researchers consider facilitating such a change? Truong’s (2014)
review of behavior change theories found Bandura’s (1986) Social Cognitive
Theory to be the most commonly used model. Other options included
Ajzen and Madden (1986) Theory of Reasoned Action; Bandura’s (1991)
Social Observation Learning Theory; Rosenstock’s (1974) Health Belief
Model; Ajzen’s (1991) Theory of Planned Behavior and Rogers (1975)
Protection Motivation Theory. Each of these models could be applied to
our research but they all lack an explicit technology link, which we believe
to be important for this study. As such we have chosen to consider Lin’s
(2003) Interactive Communication Technology Adoption Model (ICTAM)
as our theoretical framework. The ICTAM has been grounded from ele-
ments of Davis (1989) Technology Acceptance Model (TAM), so let’s now
consider the differences.
The technology acceptance model
The Technology Acceptance Model (TAM) (Davis, 1989) has been widely
used by researchers and practitioners to predict and explain user accept-
ance of information technologies (Lee et al., 2003). The TAM has been
expanded over the years to consider more specific external variables, exam-
ples include Venkatesh and Davis’ (2000) TAM2 and Venkatesh et al.’s
(2003) unified theory of acceptance and use of technology (UTAUT). The
authors have chosen to exclude these extensions because TAM2 has the
construct “Job Relevance” and the UTAUT focuses on the user. These fac-
tors are irrelevant for our research, we are looking at the acceptance of big
health data from a societal point of view. Here, the general public and
HCPs (in general1) would not use the tool, they simply provide consent for
their data to be used. Our logic is supported by Atkin et al. (2015) who
believe that such a process can be used to identify barriers that would dis-
suade clinicians from adopting new technologies, although their focus was
through the TAM. Atkin et al. (2015) also argue that the strengths of the
TAM include, its ability to predict how its attributes can influence behav-
ioral intention, actual use, and by the consideration of the barriers or
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reasons of non-adoption by looking at external variables. We contend that
the ICTAM has the same strengths because it was grounded from the
TAM. We do concede that the ICTAM’s circular framework (to be dis-
cussed in the next section) is a limitation and it is a factor that we hope to
advance. In terms of acceptance within communications, the main criticism
of the TAM has been its limited ability to process some of the more robust
communication theories, such as the adoption of emerging media channels
and contents (Lin, 2014). Lin’s (2003) ICTAM (see Figure 1) considers dif-
ferent dimensions of technology acceptance, which we believe to be import-
ant for our study. More specifically it offers a way to look at specific
factors that help shape the adoption decisions of various communication
technologies (Atkin et al., 2015). As mentioned earlier, the ICTAM is a cir-
cular model with no clear start point. This makes it cumbersome for quan-
titative research (there are no explicit dependent and independent
variables). It is however suited to qualitative studies because it can be
adapted as the framework for developing the semi-structured interview
questions, which is what we did.
Research methodology
This is an exploratory study; it has been designed to gain a deeper under-
standing of health marketeer’s beliefs in relation to centrally managing
health information. We have also decided to critically investigate the moti-
vations behind the health marketeer’s beliefs by probing further into their
reasoning then comparing it with current literature. This is why our elected
methodology was a qualitative one, more specifically we used Hsieh and
Shannon (2005) “directed content analysis” to develop the semi-structured
Figure 1. Interactive communication technology adoption model (adapted from Lin, 2003).
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interview questions, using Lin’s (2003) ICTAM as the theoretical frame-
work. Then Shaw’s (2020) adaptation of Hsieh and Shannon (2005)
“summative content analysis” to develop and identify the core themes. The
study recruited 15 participants who, at the time of interviewing, were
involved in the delivery of various national health technology initiatives
through various NHS channels in England. By limiting the participants to
individuals who were communications and marketing specialists, we were
able to identify broader themes from individuals who had the task of con-
vincing the general public to accept and sign up for big health data initia-
tives. Participants were identified with the help of contact within the NHS
Digital [the “national information and technology partner to the health and
social care system” in the UK (NHS Digital, 2021a)]. We, however,
acknowledge that the cohort was relatively small but argued that they pro-
vided a balanced understanding of how health data is collected and used.
Being able to talk to professionals that have had the experience of running
data campaigns has also helped us gain a deeper understanding of the level
of success and failure of historical and existing campaigns. As per Tracy
(2013), gaining such an understanding of the evaluation and insights from
previous studies will add further to the understanding of potential barriers.
Ethics was granted via our academic institution and interviews were con-
ducted using Microsoft Teams (a virtual video communications platform).
All interviews were between 40 and 60min and were recorded to aid tran-
scription. The transcripts were analyzed using NVivo11.
Findings and results
The primary results of this study can be presented as themes (see Table 1).
The summative content analysis approach counted the occurrence of each
Table 1. The list of themes was identified during the analysis.
Ref Theme Count % Cumulative %
1 Simple consistent messaging 55 19% 19%
2 Role of media 48 16% 35%
3 Public attitude to data use. 45 15% 50%
4 HCP attitude to data use. 42 14% 65%
5 Regulation 38 13% 78%
6 Opinion leaders 11 4% 81%
7 COVID-19 10 3% 85%
8 Care.data 9 3% 88%
9 Data use understanding 7 2% 90%
10 Information governance as a blocker 6 2% 92%
11 Complex patient conditions (data use) 6 2% 94%
12 Tole of marketeers 5 2% 96%
13 Social media 5 2% 98%
14 Opt out campaign 3 1% 99%
15 NHS Brand 2 1% 99%
16 NHS v Government 2 1% 100%
Total 294
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theme, then its cumulative percentage. Using Pareto’s 80:20 principle (see
Shaw, 2020) five core themes were extracted (giving a cumulative count of
78%). These themes helped identify the perceived core factors associated
with accepting the sharing of big health data. Each of these five themes will
now be considered in detail. Note, examples of quotes from the participants
are presented in italics with their pseudonym code at the end in brackets.
Simple consistent messaging
The first key theme identified focused on the need for simple consistent
messaging. Many of the participants believed that the constant changes in
health data messaging had left the public confused and distrustful of the
required guidelines:
I think in the beginning, when we had daily briefing [relating to the COVID-19
pandemic], everyone was so tuned in; everyone was glued to their TV… . gradually all
these other stories broke out about all this other stuff that the Government ignored the
data just shone a huge light on all of the competencies. (PA07)
I speak to a lot of technical leads2 and information governance leadsi and I recognise it
is my role as a marketeer to be able to take what they’re saying and turn it into
something that is accessible to the public. That’s really difficult, but it has to be
done. (PA11)
From this theme, we have surmised that having too many messages can
turn public confidence into confusion which then drives the mistrust.
Many of the participants also believed that some of the current terminology
used made it inaccessible to the public at large. This would again be the
catalyst for reducing engagement and trust in data use. A good example of
this dilemma can be explained using the recent COVID-19 pandemic. At
the start of the pandemic, simple messaging led by data was easy for the
public to understand as everyone played their part to “flatten the curve.”
For example, data sets like the Shielded Patient List (see NHS Digital,
2021b), which were set up in days, was able to provide local authorities
with information on members of the public that were extremely vulnerable
and enable them to provide additional support if needed.
We believe that our findings are not an outlier because, Sonuga-Barke
(2021) and Wang et al. (2020) also support the need for simple messaging
while Key and Czaplewski (2017) and Percy (2014) support the need for
consistent messaging, although Key and Czaplewski (2017) and Percy
(2014) advocate varying the style and voice for different channels (a factor
which we will be expanded on later in the article). Vanderveer (2004) takes
a different perspective, he sees simple messaging to be problematic because
its development may just focus on those features which “grab the attention”
but fail to change behavior. An example of this could be when the message
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is based on fear or guilt. Guilt and shaming can also reduce compliance
(Brennan & Binney, 2010). This means that clear, factual, and transparent
information would be the best strategy to embark upon. Based on the work
of Bouman (2017), we also believe that being able to show the journey of
data through storytelling will enable communication professionals to find
touchpoints where they can find moments to talk about health data with
the public as they interact with the NHS. These small messages will build
up over time and lead to a base level of understanding of how health data
aids their care.
The role of the media
The second theme focused on the role that media played in explaining how
health data can be used to support patient care. The first example of the
quotes used is listed below.
Traditional media is much more effective at the negative side of it; they’re really good
at creating kind of earworms that people just sort of here once, and then they will
repeat for the next 25 years. You know you hear the same story is being trotted out
about USB sticks like being left on trains. (PA05)
Two-thirds of participants cited that traditional media tended to portray
stories about the management “health data use” negatively. The results also
pointed towards a disconnect in how data was used by journalists, with
participants highlighting the fact that patient data was used primarily in
articles about health trends, for example, the rise in obesity (Boseley, 2019).
However, when discussing data used by third-party organizations, the focus
was on the data belonging to the public. A good example of this would be
the front page that ran in the Daily Mail (a national newspaper in the UK)
“Now Tesco [a national grocery store in the UK] has access to your med-
ical records: Chemists at supermarket pharmacies to be allowed to access
data in an attempt to boost care standards” (White, 2015). This indicates
that the tabloid journalists will opt for sensationalism because it helps with
their sales, a view which is shared by Schwitzer et al. (2005). Chadwick
et al. (2018, 4255) identified a more concerning issue that, “sharing tabloid
news on social media is a significant predictor of democratically dysfunc-
tional misinformation and disinformation behaviors.”
Our study also showed that false information through media channels
was an area of concern for health communication professionals. The lack
of credible information creates a breeding ground of misinformation, which
they believe to be predominantly through social media channels. These
channels have a far greater reach, and it is difficult to trace back to the
source. Examples of the participant’s comments are:
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With social media you probably receiving hundreds of little packets of information from
completely different sources. It’s much harder to counter those individual pieces of
information if they are incorrect, there is also a significant impact on people’s trust. (PA09)
If the right trigger [on social media] comes along, whether it’s positive or negative, it
can really snowball into a huge amount of interest and behaviour change that you
wouldn’t otherwise expect. (PA06)
The participants also believed that false stories had increased during the
COVID-19 pandemic. Apuke and Bahiyah (2021) presumed that much of
this is due to the speed at which false information can resonate amongst
the public. One explanation could be that the propagation of misinforma-
tion is aligned with Katz and Lazarsfeld (1966) two-step flow theory.
Essentially, if the information provided by a perceived opinion leader is
deemed to be correct by their followers then they would believe it even if it
is not. That said, the two-step flow theory can work both ways, i.e., the
perceived opinion leaders counter misinformation through their communi-
cations channels (Pang and Ng, 2017). This is reinforced by Procter et al.
(2013) who also showed that misinformation can be suppressed if the
appropriate counter-claims are disseminated. It means that health market-
eers should introduce social listening as part of their core tasks and develop
contingencies to manage misinformation.
There are also new mechanisms to counter false information, Facebook
has taken steps to remove such posts from its network (Zuckerberg, 2020)
and the UK Government has produced a counter-disinformation toolkit
using the RESIST model (Pamment, 2019). This RESIST model helps to
recognize disinformation, look for early warning, obtain some situational
insight, analyze the impact, align this to the strategic communications, and
track outcomes. A health marketeer must develop a balance of communi-
cating key messages and neutralizing incorrect information. Disinformation
is not the only problem, Smaldone et al. (2020) identified that information
can spread between like-minded online communities with a common bond:
this is similar to the two-step flow theory, only information is shared by
other communities members. Depending on the type of information being
discussed, this could either be positive or negative. Considering all these
points and the comments of our participants we now propose that provid-
ing a balance in how health data is used in their reporting is key to aiding
the public understanding and acceptance of health data use.
Public attitude to data use
The third theme is related to the attitude of the public in relation to health
data use. Our results segmented the public into three distinct groups. The
first is the expert patients, they have a vested interest in health data sharing
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and hold a lot of knowledge in the subject, but their view is focused solely
on the disease/condition they have to live with. The second is the opted-
out public, they are against data sharing and want to ensure that their right
to this premise is upheld. The final group is the rest of the general public,
this group is usually infrequent NHS users who do not seek out informa-
tion about data sharing as they already have trust that the NHS will share
and use their data appropriately. In all cases, if something gives any of
these groups a reason to think that their trust is compromised, they will
look for information from other sources which may not be accurate.
Examples of the quotes from the interviews include:
Most people would go yes, of course to sharing their data with Cancer Research UK,
but if you told people your data is being sent to researchers without your permission,
then people would think that’s outrageous. There’s still a lot of work to do to bridge
that gap of understanding. (PA12)
When you talk, what was called seldom heard voices, you see that this there is no trust
there when they see the NHS. I’ve always prided myself on the fact the NHS is a
trusted brand, but in certain areas it’s seen as the same as the Government and what
we might do with your data. They see the NHS and Government as one of the same
and just another way of getting information about them. (PA01)
We found [from user research] not that many people are interested in the subject
matter [data] they trust the NHS to hold personal patient data and they happy for the
NHS to just sort of crack on. (PA07)
Interestingly, this view aligns with the work of Malheiros et al. (2013).
Their segmentation of attitudes is divided into the following grouping:
privacy pragmatics, they look at the data ask on a case-by-case basis and
are willing to make trade-offs with their data if it provides them with a
benefit; privacy fundamentalists, are against data sharing and want to
ensure that their rights to this are upheld; privacy unconcerned, are indi-
viduals who are not concerned about data being collected about them. It
means that the message development should not adopt a “one-size fits all”
approach. Another segment that researchers need to consider is the “hard
to reach” sectors like those from the BAME (black, Asian, and minority
ethnic) communities. Our research participants believe that the BAME
community has a mistrust of the NHS which they believe is intrinsically
linked to the Government. This link makes any engagement with these
stakeholders harder:
When you talk, what was called seldom heard voices, you see that this there is no trust
there when they see the NHS. I’ve always prided myself on the fact the NHS is a
trusted brand, but in certain areas it’s seen as the same as the Government and what
we might do with your data. They see the NHS and Government as one of the same
and just another way of getting information about them. (PA01)
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All this means that researchers should consider the general public as moder-
ators when designing new studies. Arguably, these differences are down to the
varying attitudes of individuals. This is supported by current literature (see
Ahn & Black, 2018; Bagozzi & Burnkrant, 1985 and Crites et al., 1994), which
suggests that this attitude is linked to affective (does the person like the object
in question?) and cognitive (an individual’s belief about the object) compo-
nents. Yang and Yoo (2004) believe that attitude is a powerful measure of tech-
nology acceptance and should be used to enhance any future health
technology models.
Attitudes of healthcare professionals
In addition to the importance of considering the “public attitude,” our
fourth theme identified the healthcare professional’s (HCPs) attitude as
another key factor to contemplate. In terms of health data, HCPs maintain
that they need to protect patient confidentiality and its misuse. There seems
to be a communications gap as data organizations have not been feeding
back to HCPs how big data could help them and their patients. An
example could be, in aiding the commissioning of services or within clin-
ical research trials. The participants interviewed do accept that with a
workforce of over 1.4 million (NHS Digital, 2019) in England, they can
help the communications teams in disseminating key messages. The com-
munications teams must first work on changing HCP attitudes. Returning
to the interview responses we can see examples of what they told us below:
Clinicians are very clear on the benefits of using health data for the individual care of
patients. However, often it isn’t clear to them how it was used beyond that because
they don’t see the end result. (PA03)
If we can explain the clinicians the importance of the data that they input, and then
they are more likely to engage with the process, I think that’s crucial, showing them
how the data can come back and help them, that can close that loop. (PA09)
Disappointingly, despite these HCPs being employees of the NHS, it was
identified that the trust and confidence of General Practitioners with the
NHS successfully managing health data was low. Many of these GPs cited
the failure care.data campaign (discussed earlier) as their primary reason:
The campaign came across as arrogant, ’We’re going to use your data, and you’re
going to be alright with it’, and GPs didn’t like that… I think the assumption was
that people don’t really care, and it turns out they did. (PA04)
Other studies have shown that if clinical staff understand the benefits,
they can feel more comfortable talking about them to patients (Denis et al.,
2002). However, it was noted that although having advocacy from health-
care professionals is important, their obligation in terms of patient data is
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to protect the confidentiality of the patient. If healthcare professionals are
going to be used to influence behavior changes in accepting the need for
big health data, then they need to have access to the appropriate communi-
cation tools, possibly even additional training, which is supported by
Krumholz (2014) and Lee et al. (2012).
Role of regulation
The final theme identified was the role of regulation. Health marketeers
believed current regulations and governance relating to health data were
hard for the public and HCPs to understand. They considered it to be
complex and confusing, which made it difficult for General Practitioners to
explain the importance of sharing health data with their patients.
The overwhelming message that we hear from organisations and individuals out there
who need to understand the regulation and navigate regulation don’t understand
it… … It feels like there’s only a very few kind of real experts who really understand
how to make sure that they are compliant with all the range of regulations. (PA08)
There is a habit for IG [Information Governance] teams to shovel all of this legalese
into peoples in a way that we can just then say, ‘Oh, they have been informed’. We
know that they’re not… … It comes down to understanding what people need to
know what they care about. (PA01)
Information Governance is a blocker, rather an enabler. They’re seen as the ’you can’t
do something’ team, but I think that’s because that’s the role we put them in. (PA04)
These findings are in line with Anderson (2007) who identified that priv-
acy concerns were a barrier in the implementation of electronic medical
records. Papoutsi et al. (2015) also found that the general public needed to
have the reassurance that there is trustworthy governance in place and that
their health data was being shared safely and securely. Even within the
midst of the global COVID-19 pandemic, where one might posit that
the general public would succumb to such concerns, it was established that
the adoption of contact tracing mobile applications remained a challenge
because of the said privacy concerns (Hassandoust et al., 2021).
Interestingly the research participants did not mention data breaches,
hacking and malware attacks as a concern. We believe that it should be
considered because the UK’s Information Commissioner’s Office identified
that the health sector has a higher number of data breaches compared with
others (ICO, 2020).
Another finding from this study was the need for better engagement
amongst groups from diverse and differing social-economic backgrounds.
There was a perception from the participants questioned only a select
minority ever took part in their health data patient involvement groups.
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I would just love to see more of a commitment being made to meaningful public
engagement. I still feel that it’s very much still seen as a tick box exercise and that that
bothers me. (PA11)
More diversity of voices in engagement is really important. From what I’ve seen, it
often tends to be the same kind of people who were involved in kind of advocacy
around, any kind of health issue, but especially around data. (PA03)
A possible solution to this dilemma is to build on the work of the UK’s
OneLondon data programme (OneLondon, 2020). It instigated a “public
deliberation in the use of health data” using 100 people that reflected the
diverse population of London who provide them with detailed recommen-
dations and conditions that they strongly believe should be met if the use
of health data were to be expanded (HDRUK, 2020). Although the initial
consultation was successful, we will need to wait before the full results are
out. The key “take-away” reflects Papoutsi et al. (2015) earlier findings, in
that, the public needs to have the reassurance that there is trustworthy gov-
ernance in place and that their health data is being shared safely
and securely.
Having reviewed the five core themes, we now believe that a new con-
ceptual model can be presented which would supplement Lin’s (2003)
interactive communication technology adoption model particularly for
scholars who wish to embark on quantitative studies. This conceptual
model can be seen in Figure 2. The authors posit that the “attitude to use”
variable is the culmination of the effects accredited to “public attitude” and
“HCP attitude” in relation to desired behavior change. This conclusion is
based on the work of Bronfenbrenner (2005) and his “Bio-Ecology
Theory,” where the public and HCP groups become separate microsystems.
Patient data can only be amalgamated if they give their consent to do so.
Figure 2. The proposed conceptual model.
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In some cases, as identified in the study, it would be some HCPs (particu-
larly General Practitioners) who would guide patients. If these HCPs were
against the change then it could have a negative impact on the public.
Some readers may be perplexed by the model, and question if Davis
(1989) TAM model would be more appropriate. Our conceptual model has
similarities with the TAM, we have however removed the “perceived
usefulness” and “perceived ease of use” variables because the authors argue
that they are irrelevant for the general public. The public would only
experience an indirect impact of such a system. From an HCP point of
view, they already have historical local data on their patients which they
use. The authors have also assumed that the integration would be seamless,
and data would flow across multiple channels. The authors acknowledge
that this is a limitation for this study, however, it will allow for future test-
ing without additional cause and effect variables.
Limitations and future research
The authors are aware the small sample size of the participants is a limiting
factor for this research. They do, however, argue that the quality of the par-
ticipants (i.e., existing healthcare marketeers) provides a unique perspective
of the issues and adds to our understanding of the theory and knowledge
of the said domain. Further research encompassing different international
settings and/or the inclusion of the general public would enhance the
knowledge. A larger quantitative study would also allow other researchers
to test the propositions of the new model.
Conclusion
This study has taken steps to address Lupton’s (2016) concerns by critically
investigating why there is poor engagement with the sharing of Big Health
Data. From a health marketeer’s point of view, the message development
and its delivery channel mechanism were identified as the most important
factors in facilitating acceptance and behavior changes of the general public
and healthcare professionals. It should also be noted that these messages
also relate to sources outside of the health marketeer’s domain (i.e., other
bodies, of which they have no control over). This means that health mar-
keteers should monitor the keywords associated with their campaign and
implement counter strategies if fake news or misinformation has been dis-
seminated. Regulations, particularly those relating to privacy, were another
factor that was identified as having a direct and indirect effect on public
and healthcare professionals’ behavior intentions. Again, the regulation’s
message content and channel distribution can affect attitudes and
perceptions.
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Overall, we found that messages must be simple and consistent, but dif-
ferent variants were required for different segments. These variants needed
to focus on the specific concerns of that segment. Our conceptual model
can be used as a tool to evaluate healthcare messages relating to digital
data. It could be adapted for other healthcare messaging but further
research would be needed to test its efficacy.
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